Trial Profile
Open-label, single-center, randomized and parallel-group study to examine the effects of montelukast and ciclesonide on the peripheral airway inflammation in asthma using alveolar nitric oxide.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Ciclesonide (Primary) ; Montelukast (Primary) ; Corticosteroids
- Indications Asthma
- Focus Therapeutic Use
- 22 May 2013 Results presented at the 109th International Conference of the American Thoracic Society.
- 01 Mar 2010 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 22 Dec 2009 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.